Reviewer bias can significantly impact cancer research by:
Rejecting innovative or high-risk studies that could lead to breakthroughs in cancer treatment. Promoting incremental or redundant research that offers limited advancement. Discouraging young or less well-known researchers, inhibiting diversity in the field. Skewing the direction of funded research towards less impactful areas.
